Related Experiment Videos
Template-Mediated Assembly of DNA into Microcapsules for Immunological Modulation
Yijiao Qu1, Yi Ju1, Christina Cortez-Jugo1
1ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and the Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, 3010, Australia.
Small (Weinheim an Der Bergstrasse, Germany)
|August 8, 2020
Summary
New DNA microcapsules enhance vaccine adjuvants, cytosine-phosphate-guanosine oligodeoxynucleotides (CpG ODNs), by improving stability and immune response. These nanostructures offer a promising platform for effective vaccine delivery systems.
Area of Science:
- Biotechnology
- Immunology
- Nanomedicine
Background:
- Effective vaccine delivery systems and adjuvants are crucial for enhancing immune responses.
- Cytosine-phosphate-guanosine oligodeoxynucleotides (CpG ODNs) are potent immune activators but suffer from poor serum stability and cellular uptake.
- Existing vaccine formulations often contain excipients that can reduce efficacy.
Purpose of the Study:
- To develop novel DNA microcapsules for improved serum stability and enhanced immunostimulatory effects of CpG ODNs.
- To create a versatile nanostructure capable of co-delivering vaccine components and adjuvants.
- To investigate the mechanism of action and efficacy of these DNA microcapsules in cellular models.
Main Methods:
- Fabrication of 3D nanostructured DNA microcapsules loaded with CpG motifs and cargoes like glycogen.
- In vitro assessment of serum stability and cellular internalization of DNA microcapsules.
- Quantification of cytokine secretion (TNF-α, IL-6) in response to microcapsules using cell-based assays.
- Microscopic analysis (confocal, super-resolution) to track intracellular trafficking and endosomal confinement.
Main Results:
- DNA microcapsules demonstrated significantly improved serum stability compared to free CpG ODNs.
- Microcapsules efficiently delivered CpG motifs into cells, engaging Toll-like receptor 9 in endosomes.
- A substantial increase in tumor necrosis factor-α (up to 10-fold) and interleukin-6 (up to 20-fold) secretion was observed.
- Immunostimulatory activity showed concentration- and time-dependent effects, correlating with intracellular trafficking and degradation.
Conclusions:
- The developed DNA microcapsules represent a stable and effective platform for CpG ODN delivery, enhancing their immunostimulatory potential.
- These nanostructures can function as both vaccine adjuvants and delivery vehicles for synergistic immune effects.
- The findings suggest a promising approach for developing next-generation vaccines with improved efficacy and stability.